<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37359557</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The axis of complement C1 and nucleolus in antinuclear autoimmunity.</ArticleTitle><Pagination><StartPage>1196544</StartPage><MedlinePgn>1196544</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1196544</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1196544</ELocationID><Abstract><AbstractText>Antinuclear autoantibodies (ANA) are heterogeneous self-reactive antibodies that target the chromatin network, the speckled, the nucleoli, and other nuclear regions. The immunological aberration for ANA production remains partially understood, but ANA are known to be pathogenic, especially, in systemic lupus erythematosus (SLE). Most SLE patients exhibit a highly polygenic disease involving multiple organs, but in rare complement C1q, C1r, or C1s deficiencies, the disease can become largely monogenic. Increasing evidence point to intrinsic autoimmunogenicity of the nuclei. Necrotic cells release fragmented chromatins as nucleosomes and the alarmin HMGB1 is associated with the nucleosomes to activate TLRs and confer anti-chromatin autoimmunogenecity. In speckled regions, the major ANA targets Sm/RNP and SSA/Ro contain snRNAs that confer autoimmunogenecity to Sm/RNP and SSA/Ro antigens. Recently, three GAR/RGG-containing alarmins have been identified in the nucleolus that helps explain its high autoimmunogenicity. Interestingly, C1q binds to the nucleoli exposed by necrotic cells to cause protease C1r and C1s activation. C1s cleaves HMGB1 to inactive its alarmin activity. C1 proteases also degrade many nucleolar autoantigens including nucleolin, a major GAR/RGG-containing autoantigen and alarmin. It appears that the different nuclear regions are intrinsically autoimmunogenic by containing autoantigens and alarmins. However, the extracellular complement C1 complex function to dampen nuclear autoimmunogenecity by degrading these nuclear proteins.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wu, Chen, Teo, Wee, Wong, Cui, Chen, Leong and Lu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teo</LastName><ForeName>Boon Heng Dennis</ForeName><Initials>BHD</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>Seng Yin Kelly</ForeName><Initials>SYK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ming Hui Millie</ForeName><Initials>MHM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Jianzhou</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jinmiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong</LastName><ForeName>Khai Pang</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jinhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003172">Complement C1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067531">Alarmins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009707">Nucleosomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003172" MajorTopicYN="N">Complement C1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067531" MajorTopicYN="N">Alarmins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009707" MajorTopicYN="N">Nucleosomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANA</Keyword><Keyword MajorTopicYN="N">GAR/RGG</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">alarmin</Keyword><Keyword MajorTopicYN="N">complement C1</Keyword><Keyword MajorTopicYN="N">nucleolin</Keyword><Keyword MajorTopicYN="N">nucleolus autoimmunity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37359557</ArticleId><ArticleId IdType="pmc">PMC10288996</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1196544</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin (1948) 23(2):25&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18921142</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CD, Cyr M. The history of lupus erythematosus. from hippocrates to osler. Rheum Dis Clin North Am (1988) 14(1):1&#x2013;14. doi: 10.1016/S0889-857X(21)00942-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0889-857X(21)00942-X</ArticleId><ArticleId IdType="pubmed">3041483</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriz kaposi (1837-1902&#x2013;disciple of Von hebra). JAMA (1964) 187:227&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14071887</ArticleId></ArticleIdList></Reference><Reference><Citation>Baehr G, Klemperer P, Schifrin A. A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Am J Med (1952) 13(5):591&#x2013;6. doi: 10.1016/0002-9343(52)90026-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(52)90026-0</ArticleId><ArticleId IdType="pubmed">12996537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargraves MM. Production in vitro of the L.E. cell phenomenon; use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Proc Staff Meet Mayo Clin (1949) 24(9):234&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18119558</ArticleId></ArticleIdList></Reference><Reference><Citation>Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J (1957) 2(5047):732&#x2013;4. doi: 10.1136/bmj.2.5047.732</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5047.732</ArticleId><ArticleId IdType="pmc">PMC1962253</ArticleId><ArticleId IdType="pubmed">13460368</ArticleId></ArticleIdList></Reference><Reference><Citation>Damoiseaux J, von Muhlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, et al. . International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights (2016) 7(1):1. doi: 10.1007/s13317-016-0075-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13317-016-0075-0</ArticleId><ArticleId IdType="pmc">PMC4733811</ArticleId><ArticleId IdType="pubmed">26831867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura RM, Tan EM. Recent progress in the study of autoantibodies to nuclear antigens. Hum Pathol (1978) 9(1):85&#x2013;91. doi: 10.1016/S0046-8177(78)80010-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0046-8177(78)80010-0</ArticleId><ArticleId IdType="pubmed">344192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest (1967) 46(5):735&#x2013;45. doi: 10.1172/JCI105574</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI105574</ArticleId><ArticleId IdType="pmc">PMC297076</ArticleId><ArticleId IdType="pubmed">4960935</ArticleId></ArticleIdList></Reference><Reference><Citation>Stollar BD. Reactions of systemic lupus erythematosus sera with histone fractions and histone-DNA complexes. Arthritis Rheumatol (1971) 14(4):485&#x2013;92. doi: 10.1002/art.1780140408</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780140408</ArticleId><ArticleId IdType="pubmed">5314984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, et al. . Anti-U1RNP antibodies in patients with localized scieroderma. Arch Dermatol Res (2001) 293(9):455&#x2013;9. doi: 10.1007/s004030100254</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004030100254</ArticleId><ArticleId IdType="pubmed">11758788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 96(3):464&#x2013;71. doi: 10.4049/jimmunol.96.3.464</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.96.3.464</ArticleId><ArticleId IdType="pubmed">5932578</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano Y, Steen VD, Medsger TA, Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med (1993) 119(10):1005&#x2013;13. doi: 10.7326/0003-4819-119-10-199311150-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-119-10-199311150-00007</ArticleId><ArticleId IdType="pubmed">8214977</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. . Classification criteria for systemic sclerosis: an American college of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum (2013) 65(11):2737&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930146</ArticleId><ArticleId IdType="pubmed">24122180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EK, Tan EM. Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med (1987) 166(6):1627&#x2013;40. doi: 10.1084/jem.166.6.1627</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.166.6.1627</ArticleId><ArticleId IdType="pmc">PMC2188788</ArticleId><ArticleId IdType="pubmed">2445893</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo K, Hoch S, Dima C, Varga J, Teodorescu M. Circulating anticentromere CENP-a and CENP-b antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol (2000) 27(1):142&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10648030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson M, Mahler M, Pope J, You D, Tatibouet S, Steele R, et al. . Clinical correlates of CENP-a and CENP-b antibodies in a large cohort of patients with systemic sclerosis. J Rheumatol (2012) 39(4):787&#x2013;94. doi: 10.3899/rheum.111133</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/rheum.111133</ArticleId><ArticleId IdType="pubmed">22467948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, Wright TM, Curran-Everett D, West SG, et al. . Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol (2006) 33(8):1600&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16783860</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XZ, McNeilage LJ, Whittingham S. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies. Arthritis Rheumatol (1989) 32(9):1165&#x2013;9. doi: 10.1002/anr.1780320917</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anr.1780320917</ArticleId><ArticleId IdType="pubmed">2789047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs RL, Stein TW, Jr., Chan EK, Ruutu M, Tan EM. cDNA cloning and characterization of a novel nucleolar protein. Mol Biol Cell (1996) 7(7):1015&#x2013;24. doi: 10.1091/mbc.7.7.1015</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.7.7.1015</ArticleId><ArticleId IdType="pmc">PMC275955</ArticleId><ArticleId IdType="pubmed">8862517</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Ceribelli A, Hasegawa T, Tanaka S. Clinical significance of antinucleolar antibodies: biomarkers for autoimmune diseases, malignancies, and others. Clin Rev Allergy Immunol (2022) 63(2):210&#x2013;39. doi: 10.1007/s12016-022-08931-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08931-3</ArticleId><ArticleId IdType="pubmed">35258843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Marken J, Chen J, Tran VB, Li QZ, Li M, et al. . High TLR7 expression drives the expansion of CD19(+)CD24(hi)CD38(hi) transitional b cells and autoantibody production in SLE patients. Front Immunol (2019) 10:1243. doi: 10.3389/fimmu.2019.01243</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01243</ArticleId><ArticleId IdType="pmc">PMC6559307</ArticleId><ArticleId IdType="pubmed">31231380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulanet DB, Wigley FM, Gelber AC, Rosen A. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheumatol (2003) 49(1):85&#x2013;92. doi: 10.1002/art.10914</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10914</ArticleId><ArticleId IdType="pubmed">12579598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler M, Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev (2007) 6(7):432&#x2013;7. doi: 10.1016/j.autrev.2007.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2007.01.013</ArticleId><ArticleId IdType="pubmed">17643929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs RL, Lischwe MA, Spohn WH, Busch H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell (1985) 54(2):123&#x2013;33. doi: 10.1111/j.1768-322X.1985.tb00387.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1768-322X.1985.tb00387.x</ArticleId><ArticleId IdType="pubmed">2933102</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest (1987) 79(1):65&#x2013;72. doi: 10.1172/JCI112809</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI112809</ArticleId><ArticleId IdType="pmc">PMC423987</ArticleId><ArticleId IdType="pubmed">2432091</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EK, Imai H, Hamel JC, Tan EM. Human autoantibody to RNA polymerase I transcription factor hUBF. molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med (1991) 174(5):1239&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119007</ArticleId><ArticleId IdType="pubmed">1940801</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov K, Foisner R, Byrd D, Liu FT, Tsai WM, Wiik A, et al. . Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol (1995) 74(1):89&#x2013;99. doi: 10.1006/clin.1995.1013</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1995.1013</ArticleId><ArticleId IdType="pubmed">7527749</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov KN, Galcheva-Gargova Z, Hoier-Madsen M, Wiik A, Ullman S, Halberg P, et al. . Autoantibodies to lamins a and c in sera of patients showing peripheral fluorescent antinuclear antibody pattern on HEP-2 cells. J Invest Dermatol (1990) 95(3):304&#x2013;8. doi: 10.1111/1523-1747.ep12485010</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1523-1747.ep12485010</ArticleId><ArticleId IdType="pubmed">2384689</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WH, Chaudhary N, Salerno A, Blobel G. Lamin b autoantibodies in sera of certain patients with systemic lupus erythematosus. J Exp Med (1987) 165(3):750&#x2013;62. doi: 10.1084/jem.165.3.750</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.165.3.750</ArticleId><ArticleId IdType="pmc">PMC2188284</ArticleId><ArticleId IdType="pubmed">3546581</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppo P, Clauvel JP, Bengoufa D, Fuentes V, Gouilleux-Gruart V, Courvalin JC, et al. . Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides. Am J Hematol (2004) 77(3):241&#x2013;9. doi: 10.1002/ajh.20188</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.20188</ArticleId><ArticleId IdType="pubmed">15495255</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing n-acetylglucosamine residues from rat liver nuclear envelope. anti-p62 complex antibody in PBC. Mol Biol Rep (1996) 23(3-4):227&#x2013;34. doi: 10.1007/BF00351173</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00351173</ArticleId><ArticleId IdType="pubmed">9112233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Ann N Y Acad Sci (2007) 1109:519&#x2013;30. doi: 10.1196/annals.1398.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1398.058</ArticleId><ArticleId IdType="pubmed">17785341</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Kodera M, Sugiura K, Usuda T, Tan EM, Takasaki Y, et al. . Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheumatol (2004) 50(3):892&#x2013;900. doi: 10.1002/art.20096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20096</ArticleId><ArticleId IdType="pubmed">15022332</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler M, Parker T, Peebles CL, Andrade LE, Swart A, Carbone Y, et al. . Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol (2012) 39(11):2104&#x2013;10. doi: 10.3899/jrheum.120598</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.120598</ArticleId><ArticleId IdType="pubmed">22942262</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez-Del Mercado M, Gomez-Banuelos E, Navarro-Hernandez RE, Pizano-Martinez O, Saldana-Millan A, Chavarria-Avila E, et al. . Detection of autoantibodies to DSF70/LEDGFp75 in Mexican hispanics using multiple complementary assay platforms. Auto Immun Highlights (2017) 8(1):1. doi: 10.1007/s13317-016-0089-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13317-016-0089-7</ArticleId><ArticleId IdType="pmc">PMC5125105</ArticleId><ArticleId IdType="pubmed">27896669</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzani E, Drosera M, Riva S, Parodi A. Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients. Clin Lab (2012) 58(3-4):329&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22582508</ArticleId></ArticleIdList></Reference><Reference><Citation>Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, Ferri S, et al. . PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol (2010) 105(1):125&#x2013;31. doi: 10.1038/ajg.2009.596</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2009.596</ArticleId><ArticleId IdType="pubmed">19861957</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Chan JY, Ross SJ, Ceribelli A, Cavazzana I, Franceschini F, et al. . Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of d, e, f, and G proteins without other components of small nuclear ribonucleoproteins. Arthritis Rheumatol (2011) 63(7):1972&#x2013;8. doi: 10.1002/art.30349</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30349</ArticleId><ArticleId IdType="pmc">PMC3123691</ArticleId><ArticleId IdType="pubmed">21425128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, et al. . Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases. Br J Dermatol (1997) 137(6):916&#x2013;20. doi: 10.1046/j.1365-2133.1997.19852066.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2133.1997.19852066.x</ArticleId><ArticleId IdType="pubmed">9470907</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade LE, Chan EK, Raska I, Peebles CL, Roos G, Tan EM. Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med (1991) 173(6):1407&#x2013;19. doi: 10.1084/jem.173.6.1407</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.173.6.1407</ArticleId><ArticleId IdType="pmc">PMC2190846</ArticleId><ArticleId IdType="pubmed">2033369</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 121(6):2228&#x2013;34. doi: 10.4049/jimmunol.121.6.2228</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.121.6.2228</ArticleId><ArticleId IdType="pubmed">102692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler M, Miyachi K, Peebles C, Fritzler MJ. The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmun Rev (2012) 11(10):771&#x2013;5. doi: 10.1016/j.autrev.2012.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2012.02.012</ArticleId><ArticleId IdType="pubmed">22381917</ArticleId></ArticleIdList></Reference><Reference><Citation>Casiano CA, Landberg G, Ochs RL, Tan EM. Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during s phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci (1993) 106(Pt 4):1045&#x2013;56. doi: 10.1242/jcs.106.4.1045</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.106.4.1045</ArticleId><ArticleId IdType="pubmed">7907337</ArticleId></ArticleIdList></Reference><Reference><Citation>Welner S, Trier NH, Frisch M, Locht H, Hansen PR, Houen G. Correlation between centromere protein-f autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay. Mol Cancer (2013) 12(1):95. doi: 10.1186/1476-4598-12-95</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-12-95</ArticleId><ArticleId IdType="pmc">PMC3844405</ArticleId><ArticleId IdType="pubmed">23978088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock RJ, Unsworth DJ. Antibodies to extractable nuclear antigens. has technological drift affected clinical interpretation? J Clin Pathol (2001) 54(3):187&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1731369</ArticleId><ArticleId IdType="pubmed">11253128</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AS, Canoso JJ. Criteria for the classification of systemic lupus erythematosus&#x2013;status 1972. Arthritis Rheumatol (1972) 15(5):540&#x2013;3. doi: 10.1002/art.1780150512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780150512</ArticleId><ArticleId IdType="pubmed">4117792</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol (1982) 25(11):1271&#x2013;7. doi: 10.1002/art.1780251101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. . Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2012) 64(8):2677&#x2013;86. doi: 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. . European League against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2019) 71(9):1400&#x2013;12. doi: 10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeersch P, Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev (2013) 12(10):998&#x2013;1003. doi: 10.1016/j.autrev.2013.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.03.014</ArticleId><ArticleId IdType="pubmed">23583982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiepe F, Dorner T, Burmester G. Antinuclear antibody- and extractable nuclear antigen-related diseases. Int Arch Allergy Immunol (2000) 123(1):5&#x2013;9. doi: 10.1159/000024418</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000024418</ArticleId><ArticleId IdType="pubmed">11014966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 45(11):1732&#x2013;40. doi: 10.1172/JCI105479</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI105479</ArticleId><ArticleId IdType="pmc">PMC292857</ArticleId><ArticleId IdType="pubmed">4959277</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimer G, Raska I, Scheer U, Tan EM. Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus. Exp Cell Res (1988) 176(1):117&#x2013;28. doi: 10.1016/0014-4827(88)90126-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4827(88)90126-7</ArticleId><ArticleId IdType="pubmed">3286276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DL. The nucleolus: structure/function relationship in RNA metabolism. Wiley Interdiscip Rev RNA (2010) 1(3):415&#x2013;31. doi: 10.1002/wrna.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.39</ArticleId><ArticleId IdType="pubmed">21956940</ArticleId></ArticleIdList></Reference><Reference><Citation>McStay B. Nucleolar organizer regions: genomic 'dark matter' requiring illumination. Genes Dev (2016) 30(14):1598&#x2013;610. doi: 10.1101/gad.283838.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.283838.116</ArticleId><ArticleId IdType="pmc">PMC4973289</ArticleId><ArticleId IdType="pubmed">27474438</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade LEC, Damoiseaux J, Vergani D, Fritzler MJ. Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases. J Transl Autoimmun (2022) 5:100145. doi: 10.1016/j.jtauto.2022.100145</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100145</ArticleId><ArticleId IdType="pmc">PMC8804266</ArticleId><ArticleId IdType="pubmed">35128372</ArticleId></ArticleIdList></Reference><Reference><Citation>Terao C, Ohmura K, Yamada R, Kawaguchi T, Shimizu M, Tabara Y, et al. . Association between antinuclear antibodies and the HLA class II locus and heterogeneous characteristics of staining patterns: the nagahama study. Arthritis Rheumatol (2014) 66(12):3395&#x2013;403. doi: 10.1002/art.38867</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38867</ArticleId><ArticleId IdType="pubmed">25186300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Wee SYK, Chen J, Teo BHD, Ng YLC, Leong KP, et al. . Broad susceptibility of nucleolar proteins and autoantigens to complement C1 protease degradation. J Immunol (2017) 199(12):3981&#x2013;90. doi: 10.4049/jimmunol.1700728</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700728</ArticleId><ArticleId IdType="pubmed">29070672</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheer U, Xia B, Merkert H, Weisenberger D. Looking at Christmas trees in the nucleolus. Chromosoma (1997) 105(7-8):470&#x2013;80. doi: 10.1007/BF02510484</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02510484</ArticleId><ArticleId IdType="pubmed">9211975</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Cruz J, Karbstein K, Woolford JL, Jr. Functions of ribosomal proteins in assembly of eukaryotic ribosomes in vivo. Annu Rev Biochem (2015) 84:93&#x2013;129. doi: 10.1146/annurev-biochem-060614-033917</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-033917</ArticleId><ArticleId IdType="pmc">PMC4772166</ArticleId><ArticleId IdType="pubmed">25706898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatica A, Tollervey D. Making ribosomes. Curr Opin Cell Biol (2002) 14(3):313&#x2013;8. doi: 10.1016/S0955-0674(02)00336-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(02)00336-8</ArticleId><ArticleId IdType="pubmed">12067653</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschochner H, Hurt E. Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol (2003) 13(5):255&#x2013;63. doi: 10.1016/S0962-8924(03)00054-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00054-0</ArticleId><ArticleId IdType="pubmed">12742169</ArticleId></ArticleIdList></Reference><Reference><Citation>Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, et al. . Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res (2011) 71(4):1418&#x2013;30. doi: 10.1158/0008-5472.CAN-10-1728</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-1728</ArticleId><ArticleId IdType="pubmed">21159662</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson AS, Warburton D, Atwood KC. Location of ribosomal DNA in the human chromosome complement. Proc Natl Acad Sci U S A (1972) 69(11):3394&#x2013;8. doi: 10.1073/pnas.69.11.3394</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.69.11.3394</ArticleId><ArticleId IdType="pmc">PMC389778</ArticleId><ArticleId IdType="pubmed">4508329</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks MM, Kurylo CM, Dass RA, Bojmar L, Lyden D, Vincent CT, et al. . Variant ribosomal RNA alleles are conserved and exhibit tissue-specific expression. Sci Adv (2018) 4(2):eaao0665. doi: 10.1126/sciadv.aao0665</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aao0665</ArticleId><ArticleId IdType="pmc">PMC5829973</ArticleId><ArticleId IdType="pubmed">29503865</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. . The complete sequence of a human genome. Science (2022) 376(6588):44&#x2013;53. doi: 10.1126/science.abj6987</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj6987</ArticleId><ArticleId IdType="pmc">PMC9186530</ArticleId><ArticleId IdType="pubmed">35357919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Teo BHD, Cai Y, Wee SYK, Lu J. The linker histone H1.2 is a novel component of the nucleolar organizer regions. J Biol Chem (2018) 293(7):2358&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818188</ArticleId><ArticleId IdType="pubmed">29301938</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier T, Robert-Nicoud M, Guilly MN, Hernandez-Verdun D. Relocation of nucleolar proteins around chromosomes at mitosis. a study by confocal laser scanning microscopy. J Cell Sci (1992) 102(Pt 4):729&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">1429888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda Y, Maul GG. A nucleolar auto-antigen is part of a major chromosomal surface component. Chromosoma (1990) 99(2):152&#x2013;60. doi: 10.1007/BF01735332</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01735332</ArticleId><ArticleId IdType="pubmed">2192841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan EG, McGovern JH. The quantitative relationship of the fibrillar centres and other nucleolar components to changes in growth conditions, serum deprivation and low doses of actinomycin d in cultured diploid human fibroblasts (strain MRC-5). J Cell Sci (1981) 52:373&#x2013;89. doi: 10.1242/jcs.52.1.373</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.52.1.373</ArticleId><ArticleId IdType="pubmed">7334062</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung BY, Bor AM, Chan PK. Short exposure to actinomycin d induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells. Cancer Res (1990) 50(18):5987&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">1697505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong X, Melendez-Perez AJ, Reddy KL. The nuclear lamina. Cold Spring Harb Perspect Biol (2022) 14(2):1&#x2013;25. doi: 10.1101/cshperspect.a040113</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a040113</ArticleId><ArticleId IdType="pmc">PMC8805651</ArticleId><ArticleId IdType="pubmed">34400553</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steensel B, Belmont AS. Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression. Cell (2017) 169(5):780&#x2013;91. doi: 10.1016/j.cell.2017.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.022</ArticleId><ArticleId IdType="pmc">PMC5532494</ArticleId><ArticleId IdType="pubmed">28525751</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth A, Conesa A, Santoyo-Lopez J, Medina I, Montaner D, Peterfia B, et al. . Initial genomics of the human nucleolus. PloS Genet (2010) 6(3):e1000889. doi: 10.1371/journal.pgen.1000889</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000889</ArticleId><ArticleId IdType="pmc">PMC2845662</ArticleId><ArticleId IdType="pubmed">20361057</ArticleId></ArticleIdList></Reference><Reference><Citation>van Koningsbruggen S, Gierlinski M, Schofield P, Martin D, Barton GJ, Ariyurek Y, et al. . High-resolution whole-genome sequencing reveals that specific chromatin domains from most human chromosomes associate with nucleoli. Mol Biol Cell (2010) 21(21):3735&#x2013;48. doi: 10.1091/mbc.e10-06-0508</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e10-06-0508</ArticleId><ArticleId IdType="pmc">PMC2965689</ArticleId><ArticleId IdType="pubmed">20826608</ArticleId></ArticleIdList></Reference><Reference><Citation>Penagos-Puig A, Furlan-Magaril M. Heterochromatin as an important driver of genome organization. Front Cell Dev Biol (2020) 8:579137. doi: 10.3389/fcell.2020.579137</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.579137</ArticleId><ArticleId IdType="pmc">PMC7530337</ArticleId><ArticleId IdType="pubmed">33072761</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk M, Feodorova Y, Naumova N, Imakaev M, Lajoie BR, Leonhardt H, et al. . Heterochromatin drives compartmentalization of inverted and conventional nuclei. Nature (2019) 570(7761):395&#x2013;9. doi: 10.1038/s41586-019-1275-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1275-3</ArticleId><ArticleId IdType="pmc">PMC7206897</ArticleId><ArticleId IdType="pubmed">31168090</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson MO, Hingorani K, Szebeni A. Conventional and nonconventional roles of the nucleolus. Int Rev Cytol (2002) 219:199&#x2013;266. doi: 10.1016/S0074-7696(02)19014-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0074-7696(02)19014-0</ArticleId><ArticleId IdType="pmc">PMC7133188</ArticleId><ArticleId IdType="pubmed">12211630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam YW, Evans VC, Heesom KJ, Lamond AI, Matthews DA. Proteomics analysis of the nucleolus in adenovirus-infected cells. Mol Cell Proteomics (2010) 9(1):117&#x2013;30. doi: 10.1074/mcp.M900338-MCP200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M900338-MCP200</ArticleId><ArticleId IdType="pmc">PMC2808258</ArticleId><ArticleId IdType="pubmed">19812395</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, et al. . Directed proteomic analysis of the human nucleolus. Curr Biol (2002) 12(1):1&#x2013;11. doi: 10.1016/S0960-9822(01)00650-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(01)00650-9</ArticleId><ArticleId IdType="pubmed">11790298</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore HM, Bai B, Boisvert FM, Latonen L, Rantanen V, Simpson JC, et al. . Quantitative proteomics and dynamic imaging of the nucleolus reveal distinct responses to UV and ionizing radiation. Mol Cell Proteomics (2011) 10(10):M111 009241. doi: 10.1074/mcp.M111.009241</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.009241</ArticleId><ArticleId IdType="pmc">PMC3205868</ArticleId><ArticleId IdType="pubmed">21778410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad Y, Boisvert FM, Gregor P, Cobley A, Lamond AI. NOPdb: nucleolar proteome database&#x2013;2008 update. Nucleic Acids Res (2009) 37(Database issue):D181&#x2013;4. doi: 10.1093/nar/gkn804</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn804</ArticleId><ArticleId IdType="pmc">PMC2686505</ArticleId><ArticleId IdType="pubmed">18984612</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell J, Zomerdijk JC. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem Sci (2005) 30(2):87&#x2013;96. doi: 10.1016/j.tibs.2004.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2004.12.008</ArticleId><ArticleId IdType="pmc">PMC3858833</ArticleId><ArticleId IdType="pubmed">15691654</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel P, Andre C, Masson C, Geraud G, Hernandez-Verdun D. Localization of the RNA polymerase I transcription factor hUBF during the cell cycle. J Cell Sci (1993) 104(Pt 2):327&#x2013;37. doi: 10.1242/jcs.104.2.327</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.104.2.327</ArticleId><ArticleId IdType="pubmed">8505363</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan AC, Sullivan GJ, McStay B. UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol Cell Biol (2002) 22(2):657&#x2013;68. doi: 10.1128/MCB.22.2.657-668.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.2.657-668.2002</ArticleId><ArticleId IdType="pmc">PMC139743</ArticleId><ArticleId IdType="pubmed">11756560</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanovsky VY, Pelletier G, Bazett-Jones DP, Crane-Robinson C, Moss T. DNA Looping in the RNA polymerase I enhancesome is the result of non-cooperative in-phase bending by two UBF molecules. Nucleic Acids Res (2001) 29(15):3241&#x2013;7. doi: 10.1093/nar/29.15.3241</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.15.3241</ArticleId><ArticleId IdType="pmc">PMC55825</ArticleId><ArticleId IdType="pubmed">11470882</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller OL, Jr., Beatty BR. Visualization of nucleolar genes. Science (1969) 164(3882):955&#x2013;7. doi: 10.1126/science.164.3882.955</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.164.3882.955</ArticleId><ArticleId IdType="pubmed">5813982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougey EB, O'Reilly M, Osheim Y, Miller OL, Jr., Beyer A, Sollner-Webb B. The terminal balls characteristic of eukaryotic rRNA transcription units in chromatin spreads are rRNA processing complexes. Genes Dev (1993) 7(8):1609&#x2013;19. doi: 10.1101/gad.7.8.1609</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.7.8.1609</ArticleId><ArticleId IdType="pubmed">8339936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheutin T, O'Donohue MF, Beorchia A, Vandelaer M, Kaplan H, Defever B, et al. . Three-dimensional organization of active rRNA genes within the nucleolus. J Cell Sci (2002) 115(Pt 16):3297&#x2013;307. doi: 10.1242/jcs.115.16.3297</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.115.16.3297</ArticleId><ArticleId IdType="pubmed">12140261</ArticleId></ArticleIdList></Reference><Reference><Citation>Koberna K, Malinsky J, Pliss A, Masata M, Vecerova J, Fialova M, et al. . Ribosomal genes in focus: new transcripts label the dense fibrillar components and form clusters indicative of "Christmas trees" in situ. J Cell Biol (2002) 157(5):743&#x2013;8. doi: 10.1083/jcb.200202007</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200202007</ArticleId><ArticleId IdType="pmc">PMC2173423</ArticleId><ArticleId IdType="pubmed">12034768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez IL, Sylvester JE. Complete sequence of the 43-kb human ribosomal DNA repeat: analysis of the intergenic spacer. Genomics (1995) 27(2):320&#x2013;8. doi: 10.1006/geno.1995.1049</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1995.1049</ArticleId><ArticleId IdType="pubmed">7557999</ArticleId></ArticleIdList></Reference><Reference><Citation>Potapova TA, Gerton JL. Ribosomal DNA and the nucleolus in the context of genome organization. Chromosome Res (2019) 27(1-2):109&#x2013;27. doi: 10.1007/s10577-018-9600-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10577-018-9600-5</ArticleId><ArticleId IdType="pubmed">30656516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard F, Igelmann S, Trahan C, Huot G, Saint-Germain E, Mignacca L, et al. . Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nat Cell Biol (2018) 20(7):789&#x2013;99. doi: 10.1038/s41556-018-0127-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0127-y</ArticleId><ArticleId IdType="pubmed">29941930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafontaine DL. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat Struct Mol Biol (2015) 22(1):11&#x2013;9. doi: 10.1038/nsmb.2939</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2939</ArticleId><ArticleId IdType="pubmed">25565028</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins NJ, Bohnsack MT. The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdiscip Rev RNA (2012) 3(3):397&#x2013;414. doi: 10.1002/wrna.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.117</ArticleId><ArticleId IdType="pubmed">22065625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Fayet E, Jady BE, Richard P, Weber M. Biogenesis and intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring Harb Symp Quant Biol (2006) 71:407&#x2013;17. doi: 10.1101/sqb.2006.71.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2006.71.025</ArticleId><ArticleId IdType="pubmed">17381323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunziker M, Barandun J, Petfalski E, Tan D, Delan-Forino C, Molloy KR, et al. . UtpA and UtpB chaperone nascent pre-ribosomal RNA and U3 snoRNA to initiate eukaryotic ribosome assembly. Nat Commun (2016) 7:12090. doi: 10.1038/ncomms12090</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12090</ArticleId><ArticleId IdType="pmc">PMC4931317</ArticleId><ArticleId IdType="pubmed">27354316</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaker-Margot M, Hunziker M, Barandun J, Dill BD, Klinge S. Stage-specific assembly events of the 6-MDa small-subunit processome initiate eukaryotic ribosome biogenesis. Nat Struct Mol Biol (2015) 22(11):920&#x2013;3. doi: 10.1038/nsmb.3111</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3111</ArticleId><ArticleId IdType="pubmed">26479197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lestrade L, Weber MJ. snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res (2006) 34(Database issue):D158&#x2013;62. doi: 10.1093/nar/gkj002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj002</ArticleId><ArticleId IdType="pmc">PMC1347365</ArticleId><ArticleId IdType="pubmed">16381836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard-Bourelle P, Desjardins-Henri C, Mathurin-St-Pierre D, Deschamps-Francoeur G, Fafard-Couture E, Garant JM, et al. . snoDB: an interactive database of human snoRNA sequences, abundance and interactions. Nucleic Acids Res (2020) 48(D1):D220&#x2013;D5. doi: 10.1093/nar/gkz884</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz884</ArticleId><ArticleId IdType="pmc">PMC6943035</ArticleId><ArticleId IdType="pubmed">31598696</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorjani H, Kehr S, Jedlinski DJ, Gumienny R, Hertel J, Stadler PF, et al. . An updated human snoRNAome. Nucleic Acids Res (2016) 44(11):5068&#x2013;82. doi: 10.1093/nar/gkw386</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw386</ArticleId><ArticleId IdType="pmc">PMC4914119</ArticleId><ArticleId IdType="pubmed">27174936</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogh N, Jansson MD, Hafner SJ, Tehler D, Birkedal U, Christensen-Dalsgaard M, et al. . Profiling of 2'-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res (2016) 44(16):7884&#x2013;95. doi: 10.1093/nar/gkw482</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw482</ArticleId><ArticleId IdType="pmc">PMC5027482</ArticleId><ArticleId IdType="pubmed">27257078</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimer G, Steen VD, Penning CA, Medsger TA, Jr., Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheumatol (1988) 31(4):525&#x2013;32. doi: 10.1002/art.1780310409</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780310409</ArticleId><ArticleId IdType="pubmed">2451921</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics (2009) 94(2):83&#x2013;8. doi: 10.1016/j.ygeno.2009.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2009.05.002</ArticleId><ArticleId IdType="pubmed">19446021</ArticleId></ArticleIdList></Reference><Reference><Citation>Terns M, Terns R. Noncoding RNAs of the H/ACA family. Cold Spring Harb Symp Quant Biol (2006) 71:395&#x2013;405. doi: 10.1101/sqb.2006.71.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2006.71.034</ArticleId><ArticleId IdType="pubmed">17381322</ArticleId></ArticleIdList></Reference><Reference><Citation>Massenet S, Bertrand E, Verheggen C. Assembly and trafficking of box C/D and H/ACA snoRNPs. RNA Biol (2017) 14(6):680&#x2013;92. doi: 10.1080/15476286.2016.1243646</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1243646</ArticleId><ArticleId IdType="pmc">PMC5519232</ArticleId><ArticleId IdType="pubmed">27715451</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Frey MR, Matera AG. Human genes encoding U3 snRNA associate with coiled bodies in interphase cells and are clustered on chromosome 17p11.2 in a complex inverted repeat structure. Nucleic Acids Res (1997) 25(23):4740&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC147103</ArticleId><ArticleId IdType="pubmed">9365252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kufel J, Allmang C, Chanfreau G, Petfalski E, Lafontaine DL, Tollervey D. Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by la binding. Mol Cell Biol (2000) 20(15):5415&#x2013;24. doi: 10.1128/MCB.20.15.5415-5424.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.15.5415-5424.2000</ArticleId><ArticleId IdType="pmc">PMC85993</ArticleId><ArticleId IdType="pubmed">10891482</ArticleId></ArticleIdList></Reference><Reference><Citation>Samarsky DA, Fournier MJ, Singer RH, Bertrand E. The snoRNA box C/D motif directs nucleolar targeting and also couples snoRNA synthesis and localization. EMBO J (1998) 17(13):3747&#x2013;57. doi: 10.1093/emboj/17.13.3747</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.13.3747</ArticleId><ArticleId IdType="pmc">PMC1170710</ArticleId><ArticleId IdType="pubmed">9649444</ArticleId></ArticleIdList></Reference><Reference><Citation>Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol (2007) 8(3):209&#x2013;20. doi: 10.1038/nrm2124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2124</ArticleId><ArticleId IdType="pubmed">17318225</ArticleId></ArticleIdList></Reference><Reference><Citation>Barandun J, Chaker-Margot M, Hunziker M, Molloy KR, Chait BT, Klinge S. The complete structure of the small-subunit processome. Nat Struct Mol Biol (2017) 24(11):944&#x2013;53. doi: 10.1038/nsmb.3472</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3472</ArticleId><ArticleId IdType="pubmed">28945246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lischwe MA, Smetana K, Olson MO, Busch H. Proteins C23 and B23 are the major nucleolar silver staining proteins. Life Sci (1979) 25(8):701&#x2013;8. doi: 10.1016/0024-3205(79)90512-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(79)90512-5</ArticleId><ArticleId IdType="pubmed">91938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YP, Busch RK, Valdez BC, Busch H. C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. Eur J Biochem (1996) 237(1):153&#x2013;8. doi: 10.1111/j.1432-1033.1996.0153n.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1996.0153n.x</ArticleId><ArticleId IdType="pubmed">8620867</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Knox AA, Prieto JL, McStay B, Watkins NJ. A novel small-subunit processome assembly intermediate that contains the U3 snoRNP, nucleolin, RRP5, and DBP4. Mol Cell Biol (2009) 29(11):3007&#x2013;17. doi: 10.1128/MCB.00029-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00029-09</ArticleId><ArticleId IdType="pmc">PMC2682003</ArticleId><ArticleId IdType="pubmed">19332556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindstrom MS. NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int (2011) 2011:195209. doi: 10.1155/2011/195209</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/195209</ArticleId><ArticleId IdType="pmc">PMC2989734</ArticleId><ArticleId IdType="pubmed">21152184</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard C, Will CL, Peng J, Makarov EM, Kastner B, Lemm I, et al. . Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat Commun (2012) 3:994. doi: 10.1038/ncomms1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1998</ArticleId><ArticleId IdType="pubmed">22871813</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias AP, Dufu K, Lei H, Reed R. A role for TREX components in the release of spliced mRNA from nuclear speckle domains. Nat Commun (2010) 1:97. doi: 10.1038/ncomms1103</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1103</ArticleId><ArticleId IdType="pmc">PMC3793428</ArticleId><ArticleId IdType="pubmed">20981025</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman GJ, Vas J, Gronwall C. Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat Rev Rheumatol (2013) 9(5):291&#x2013;300. doi: 10.1038/nrrheum.2013.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.30</ArticleId><ArticleId IdType="pubmed">23507902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human b cell precursors. Science (2003) 301(5638):1374&#x2013;7. doi: 10.1126/science.1086907</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086907</ArticleId><ArticleId IdType="pubmed">12920303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, et al. . Defective b cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 201(5):703&#x2013;11. doi: 10.1084/jem.20042251</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20042251</ArticleId><ArticleId IdType="pmc">PMC2212839</ArticleId><ArticleId IdType="pubmed">15738055</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, et al. . Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A (2008) 105(28):9727&#x2013;32. doi: 10.1073/pnas.0803644105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803644105</ArticleId><ArticleId IdType="pmc">PMC2474524</ArticleId><ArticleId IdType="pubmed">18621685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 28:367&#x2013;88. doi: 10.1146/annurev.immunol.021908.132603</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132603</ArticleId><ArticleId IdType="pubmed">20192808</ArticleId></ArticleIdList></Reference><Reference><Citation>Das N, Dewan V, Grace PM, Gunn RJ, Tamura R, Tzarum N, et al. . HMGB1 activates proinflammatory signaling via TLR5 leading to allodynia. Cell Rep (2016) 17(4):1128&#x2013;40. doi: 10.1016/j.celrep.2016.09.076</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.076</ArticleId><ArticleId IdType="pmc">PMC5087801</ArticleId><ArticleId IdType="pubmed">27760316</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, et al. . Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med (2008) 205(13):3007&#x2013;18. doi: 10.1084/jem.20081165</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20081165</ArticleId><ArticleId IdType="pmc">PMC2605236</ArticleId><ArticleId IdType="pubmed">19064698</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter R, Luhrmann R. Immunization of mice with purified U1 small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies. Proc Natl Acad Sci U S A (1986) 83(22):8689&#x2013;93. doi: 10.1073/pnas.83.22.8689</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.22.8689</ArticleId><ArticleId IdType="pmc">PMC386996</ArticleId><ArticleId IdType="pubmed">2430297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly-Scumpia KM, Nacionales DC, Scumpia PO, Weinstein JS, Narain S, Moldawer LL, et al. . In vivo adjuvant activity of the RNA component of the Sm/RNP lupus autoantigen. Arthritis Rheumatol (2007) 56(10):3379&#x2013;86. doi: 10.1002/art.22946</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22946</ArticleId><ArticleId IdType="pubmed">17907192</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin MS, Kang Y, Lee N, Kim SH, Kang KS, Lazova R, et al. . U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol (2012) 188(10):4769&#x2013;75. doi: 10.4049/jimmunol.1103355</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103355</ArticleId><ArticleId IdType="pmc">PMC3347773</ArticleId><ArticleId IdType="pubmed">22490866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly KM, Zhuang H, Nacionales DC, Scumpia PO, Lyons R, Akaogi J, et al. . "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and ro 60. Arthritis Rheumatol (2006) 54(5):1557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">16645989</ArticleId></ArticleIdList></Reference><Reference><Citation>Welting TJ, Raijmakers R, Pruijn GJ. Autoantigenicity of nucleolar complexes. Autoimmun Rev (2003) 2(6):313&#x2013;21. doi: 10.1016/S1568-9972(03)00029-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1568-9972(03)00029-6</ArticleId><ArticleId IdType="pubmed">14550872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Teo BHD, Wee SYK, Chen J, Lu J. The GAR/RGG motif defines a family of nuclear alarmins. Cell Death Dis (2021) 12(5):477. doi: 10.1038/s41419-021-03766-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03766-w</ArticleId><ArticleId IdType="pmc">PMC8116331</ArticleId><ArticleId IdType="pubmed">33980825</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med (2005) 11(1):85&#x2013;9. doi: 10.1038/nm1167</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1167</ArticleId><ArticleId IdType="pubmed">15619631</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole BD, Gross T, Maier S, Harley JB, James JA. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J Autoimmun (2008) 31(4):362&#x2013;71. doi: 10.1016/j.jaut.2008.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2008.08.007</ArticleId><ArticleId IdType="pmc">PMC2852321</ArticleId><ArticleId IdType="pubmed">18849143</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Oudit O, Hajtovic S, Sarbaugh D, Salis R, Adebowale T, et al. . Antibodies to an Epstein Barr virus protein that cross-react with dsDNA have pathogenic potential. Mol Immunol (2021) 132:41&#x2013;52. doi: 10.1016/j.molimm.2021.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.01.013</ArticleId><ArticleId IdType="pubmed">33545624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubian H, Frohlich T, Pogodski D, Flatley A, Kremmer E, Schepers A, et al. . Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation. J Gen Virol (2017) 98(8):2128&#x2013;42. doi: 10.1099/jgv.0.000870</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000870</ArticleId><ArticleId IdType="pubmed">28758620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther (2003) 5(2):80&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165038</ArticleId><ArticleId IdType="pubmed">12718748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JM, Hildebrandt B, Luderschmidt C, Pollard KM. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis Rheumatol (2003) 48(1):210&#x2013;7. doi: 10.1002/art.10729</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10729</ArticleId><ArticleId IdType="pubmed">12528121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis (2002) 61(9):842&#x2013;6. doi: 10.1136/ard.61.9.842</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.61.9.842</ArticleId><ArticleId IdType="pmc">PMC1754228</ArticleId><ArticleId IdType="pubmed">12176814</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eenennaam H, Vogelzangs JH, Bisschops L, Te Boome LC, Seelig HP, Renz M, et al. . Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin Exp Immunol (2002) 130(3):532&#x2013;40. doi: 10.1046/j.1365-2249.2002.01991.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2002.01991.x</ArticleId><ArticleId IdType="pmc">PMC1906554</ArticleId><ArticleId IdType="pubmed">12452846</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. . 2016 American College of Rheumatology/European league against rheumatism classification criteria for primary sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol (2017) 69(1):35&#x2013;45. doi: 10.1002/art.39859</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39859</ArticleId><ArticleId IdType="pmc">PMC5650478</ArticleId><ArticleId IdType="pubmed">27785888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata D, Iwamoto M, Yoshio T, Okazaki H, Masuyama J, Mimori A, et al. . Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice. Clin Immunol (2000) 97(1):50&#x2013;8. doi: 10.1006/clim.2000.4916</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2000.4916</ArticleId><ArticleId IdType="pubmed">10998317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindas-Mugge I. Human autoantibodies against a nucleolar protein. Biochem Biophys Res Commun (1989) 163(2):1119&#x2013;27. doi: 10.1016/0006-291X(89)92337-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(89)92337-1</ArticleId><ArticleId IdType="pubmed">2675830</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifle J, Anderer FA, Franke M. Characterisation of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis (1986) 45(12):978&#x2013;86. doi: 10.1136/ard.45.12.978</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.45.12.978</ArticleId><ArticleId IdType="pmc">PMC1002036</ArticleId><ArticleId IdType="pubmed">3545105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie RF. Antinucleolar antibodies. their frequency and diagnostic association. N Engl J Med (1970) 282(21):1174&#x2013;8. doi: 10.1056/NEJM197005212822104</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197005212822104</ArticleId><ArticleId IdType="pubmed">4909324</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA. Anti-NOR 90. a new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol (1987) 139(8):2579&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">3309055</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher JH, Scheer U, Voit R, Grummt I, Lonzetti L, Raymond Y, et al. . Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response. J Rheumatol (2002) 29(7):1543&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12136917</ArticleId></ArticleIdList></Reference><Reference><Citation>Brankin B, Skaar TC, Brotzman M, Trock B, Clarke R. Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 7(12):1109&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9865429</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai H, Ochs RL, Kiyosawa K, Nakamura RM, Tan EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol (1992) 140(4):859&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886358</ArticleId><ArticleId IdType="pubmed">1314027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JY, Wang X, Peng XX, Chan EK. Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol (2002) 22(2):98&#x2013;105. doi: 10.1023/A:1014483803483</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1014483803483</ArticleId><ArticleId IdType="pubmed">11998899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogg SC, Lamond AI. Cajal bodies and coilin&#x2013;moving towards function. J Cell Biol (2002) 159(1):17&#x2013;21. doi: 10.1083/jcb.200206111</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200206111</ArticleId><ArticleId IdType="pmc">PMC2173504</ArticleId><ArticleId IdType="pubmed">12379800</ArticleId></ArticleIdList></Reference><Reference><Citation>Machyna M, Kehr S, Straube K, Kappei D, Buchholz F, Butter F, et al. . The coilin interactome identifies hundreds of small noncoding RNAs that traffic through cajal bodies. Mol Cell (2014) 56(3):389&#x2013;99. doi: 10.1016/j.molcel.2014.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.10.004</ArticleId><ArticleId IdType="pubmed">25514182</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkle-Mulcahy L, Sleeman JE. The cajal body and the nucleolus: "In a relationship" or "It's complicated"? RNA Biol (2017) 14(6):739&#x2013;51. doi: 10.1080/15476286.2016.1236169</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1236169</ArticleId><ArticleId IdType="pmc">PMC5519233</ArticleId><ArticleId IdType="pubmed">27661468</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilders G, van Dijk E, Raijmakers R, Pruijn GJ. Cell and molecular biology of the exosome: how to make or break an RNA. Int Rev Cytol (2006) 251:159&#x2013;208. doi: 10.1016/S0074-7696(06)51005-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0074-7696(06)51005-8</ArticleId><ArticleId IdType="pubmed">16939780</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer R, Pruijn GJ, van Venrooij WJ. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res (2001) 3(2):102&#x2013;6. doi: 10.1186/ar147</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar147</ArticleId><ArticleId IdType="pmc">PMC128886</ArticleId><ArticleId IdType="pubmed">11178117</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson MR, Cao LG, Wang YL, Pederson T. Dynamic localization of RNase MRP RNA in the nucleolus observed by fluorescent RNA cytochemistry in living cells. J Cell Biol (1995) 131(Pt 2):1649&#x2013;58. doi: 10.1083/jcb.131.6.1649</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.131.6.1649</ArticleId><ArticleId IdType="pmc">PMC2120670</ArticleId><ArticleId IdType="pubmed">8557735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrous N, Wolenski JS, Wesolowski D, Lee C, Altman S. Localization in the nucleolus and coiled bodies of protein subunits of the ribonucleoprotein ribonuclease p. J Cell Biol (1999) 146(3):559&#x2013;72. doi: 10.1083/jcb.146.3.559</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.146.3.559</ArticleId><ArticleId IdType="pmc">PMC2150555</ArticleId><ArticleId IdType="pubmed">10444065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner EA, Lerner MR, Janeway CA, Jr., Steitz JA. Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci U S A (1981) 78(5):2737&#x2013;41. doi: 10.1073/pnas.78.5.2737</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.78.5.2737</ArticleId><ArticleId IdType="pmc">PMC319432</ArticleId><ArticleId IdType="pubmed">6789322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Uchiumi T, Arakawa M, Kominami R. Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain. Clin Exp Immunol (1994) 98(1):35&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1534158</ArticleId><ArticleId IdType="pubmed">7923881</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Tsao BP. Advances in lupus genetics and epigenetics. Curr Opin Rheumatol (2014) 26(5):482&#x2013;92. doi: 10.1097/BOR.0000000000000086</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000086</ArticleId><ArticleId IdType="pmc">PMC4222581</ArticleId><ArticleId IdType="pubmed">25010439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun (2013) 41:25&#x2013;33. doi: 10.1016/j.jaut.2013.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.01.008</ArticleId><ArticleId IdType="pubmed">23395425</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol (2017) 29(5):423&#x2013;33. doi: 10.1097/BOR.0000000000000411</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000411</ArticleId><ArticleId IdType="pubmed">28509669</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, et al. . Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun (2017) 8:16021. doi: 10.1038/ncomms16021</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Kim K, Suetsugu H, Bang SY, Wen L, Koido M, et al. . Meta-analysis of 208370 East asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann Rheum Dis (2021) 80(5):632&#x2013;40. doi: 10.1136/annrheumdis-2020-219209</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219209</ArticleId><ArticleId IdType="pmc">PMC8053352</ArticleId><ArticleId IdType="pubmed">33272962</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser KL, Kelly JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun (2009) 10(5):373&#x2013;9. doi: 10.1038/gene.2009.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.39</ArticleId><ArticleId IdType="pmc">PMC3144759</ArticleId><ArticleId IdType="pubmed">19440199</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol (2006) 28(2):119&#x2013;30. doi: 10.1007/s00281-006-0040-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-006-0040-5</ArticleId><ArticleId IdType="pubmed">17021721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HS, Bae SC. Recent advances in systemic lupus erythematosus genetics in an Asian population. Int J Rheum Dis (2015) 18(2):192&#x2013;9. doi: 10.1111/1756-185X.12498</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12498</ArticleId><ArticleId IdType="pubmed">25522798</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes B, Vyse TJ. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatol (Oxford) (2008) 47(11):1603&#x2013;11. doi: 10.1093/rheumatology/ken247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken247</ArticleId><ArticleId IdType="pubmed">18611920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada T, Fujimori D, Yamamoto Y. Systemic lupus erythematosus and immunodeficiency. Immunol Med (2019) 42(1):1&#x2013;9. doi: 10.1080/25785826.2019.1628466</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/25785826.2019.1628466</ArticleId><ArticleId IdType="pubmed">31204893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodke-Puranik Y, Niewold TB. Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun (2015) 64:125&#x2013;36. doi: 10.1016/j.jaut.2015.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4628859</ArticleId><ArticleId IdType="pubmed">26324017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Shaftman SR, Ward RC, Langefeld CD. Genes associated with SLE are targets of recent positive selection. Autoimmune Dis (2014) 2014:203435. doi: 10.1155/2014/203435</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/203435</ArticleId><ArticleId IdType="pmc">PMC3920976</ArticleId><ArticleId IdType="pubmed">24587899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HW, Barber G, Chong BF. The genetic landscape of cutaneous lupus erythematosus. Front Med (Lausanne) (2022) 9:916011. doi: 10.3389/fmed.2022.916011</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.916011</ArticleId><ArticleId IdType="pmc">PMC9201079</ArticleId><ArticleId IdType="pubmed">35721085</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 6(12):683&#x2013;92. doi: 10.1038/nrrheum.2010.176</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2010.176</ArticleId><ArticleId IdType="pmc">PMC3135416</ArticleId><ArticleId IdType="pubmed">21060334</ArticleId></ArticleIdList></Reference><Reference><Citation>Fike AJ, Elcheva I, Rahman ZSM. The post-GWAS era: how to validate the contribution of gene variants in lupus. Curr Rheumatol Rep (2019) 21(1):3. doi: 10.1007/s11926-019-0801-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-019-0801-5</ArticleId><ArticleId IdType="pubmed">30673885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn SE, Kottyan LC, Munroe ME, Harley JB. Genetic susceptibility to lupus: the biological basis of genetic risk found in b cell signaling pathways. J Leukoc Biol (2012) 92(3):577&#x2013;91. doi: 10.1189/jlb.0212095</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0212095</ArticleId><ArticleId IdType="pmc">PMC3748338</ArticleId><ArticleId IdType="pubmed">22753952</ArticleId></ArticleIdList></Reference><Reference><Citation>Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA. Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol (2010) 6(3):461&#x2013;79. doi: 10.1586/eci.10.8</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.10.8</ArticleId><ArticleId IdType="pmc">PMC2897739</ArticleId><ArticleId IdType="pubmed">20441431</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Hom G, Ortmann W, Behrens TW. Review of recent genome-wide association scans in lupus. J Intern Med (2009) 265(6):680&#x2013;8. doi: 10.1111/j.1365-2796.2009.02096.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2009.02096.x</ArticleId><ArticleId IdType="pubmed">19493061</ArticleId></ArticleIdList></Reference><Reference><Citation>Suurmond J, Calise J, Malkiel S, Diamond B. DNA-Reactive b cells in lupus. Curr Opin Immunol (2016) 43:1&#x2013;7. doi: 10.1016/j.coi.2016.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.07.002</ArticleId><ArticleId IdType="pmc">PMC5125853</ArticleId><ArticleId IdType="pubmed">27504587</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid KBM. Complement component C1q: historical perspective of a functionally versatile, and structurally unusual, serum protein. Front Immunol (2018) 9:764. doi: 10.3389/fimmu.2018.00764</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00764</ArticleId><ArticleId IdType="pmc">PMC5902488</ArticleId><ArticleId IdType="pubmed">29692784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Kishore U. C1 complex: an adaptable proteolytic module for complement and non-complement functions. Front Immunol (2017) 8:592. doi: 10.3389/fimmu.2017.00592</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00592</ArticleId><ArticleId IdType="pmc">PMC5442170</ArticleId><ArticleId IdType="pubmed">28596769</ArticleId></ArticleIdList></Reference><Reference><Citation>Alperin JM, Ortiz-Fernandez L, Sawalha AH. Monogenic lupus: a developing paradigm of disease. Front Immunol (2018) 9:2496. doi: 10.3389/fimmu.2018.02496</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02496</ArticleId><ArticleId IdType="pmc">PMC6232876</ArticleId><ArticleId IdType="pubmed">30459768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 76:227&#x2013;324. doi: 10.1016/S0065-2776(01)76021-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(01)76021-X</ArticleId><ArticleId IdType="pubmed">11079100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MJ, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity (2006) 39(5):367&#x2013;78. doi: 10.1080/08916930600739233</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930600739233</ArticleId><ArticleId IdType="pubmed">16923536</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid KB. Activation and control of the complement system. Essays Biochem (1986) 22:27&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">3549286</ArticleId></ArticleIdList></Reference><Reference><Citation>Walport MJ. Complement. First Two Parts N Engl J Med (2001) 344(14):1058&#x2013;66. doi: 10.1056/NEJM200104053441406</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200104053441406</ArticleId><ArticleId IdType="pubmed">11287977</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol (1997) 158(10):4525&#x2013;8. doi: 10.4049/jimmunol.158.10.4525</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.158.10.4525</ArticleId><ArticleId IdType="pubmed">9144462</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol (2018) 36:489&#x2013;517. doi: 10.1146/annurev-immunol-042617-053010</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053010</ArticleId><ArticleId IdType="pubmed">29400998</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, et al. . Clearance deficiency&#x2013;a potential link between infections and autoimmunity. Autoimmun Rev (2008) 8(1):5&#x2013;8. doi: 10.1016/j.autrev.2008.07.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.07.049</ArticleId><ArticleId IdType="pubmed">18790092</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay IR, Leskovsek NV, Rose NR. Cell damage and autoimmunity: a critical appraisal. J Autoimmun (2008) 30(1-2):5&#x2013;11. doi: 10.1016/j.jaut.2007.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2007.11.009</ArticleId><ArticleId IdType="pmc">PMC2231525</ArticleId><ArticleId IdType="pubmed">18194728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 188(2):387&#x2013;92. doi: 10.1084/jem.188.2.387</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.188.2.387</ArticleId><ArticleId IdType="pmc">PMC2212450</ArticleId><ArticleId IdType="pubmed">9670050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, et al. . C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 194(6):781&#x2013;95. doi: 10.1084/jem.194.6.781</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.194.6.781</ArticleId><ArticleId IdType="pmc">PMC2195958</ArticleId><ArticleId IdType="pubmed">11560994</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol (2012) 188(11):5682&#x2013;93. doi: 10.4049/jimmunol.1103760</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103760</ArticleId><ArticleId IdType="pmc">PMC3358549</ArticleId><ArticleId IdType="pubmed">22523386</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol (2014) 14(3):166&#x2013;80. doi: 10.1038/nri3607</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3607</ArticleId><ArticleId IdType="pmc">PMC4040260</ArticleId><ArticleId IdType="pubmed">24481336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Teo BH, Yeo JG, Lu J. C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins. J Biol Chem (2015) 290(37):22570&#x2013;80. doi: 10.1074/jbc.M115.670661</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.670661</ArticleId><ArticleId IdType="pmc">PMC4566231</ArticleId><ArticleId IdType="pubmed">26231209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr FK, O'Brien G, Quinsey NS, Whisstock JC, Boyd S, de la Banda MG, et al. . Elucidation of the substrate specificity of the C1s protease of the classical complement pathway. J Biol Chem (2005) 280(47):39510&#x2013;4. doi: 10.1074/jbc.M506131200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506131200</ArticleId><ArticleId IdType="pubmed">16169853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo JG, Leong J, Arkachaisri T, Cai Y, Teo BH, Tan JH, et al. . Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis. Cell Death Discovery (2016) 2:16069. doi: 10.1038/cddiscovery.2016.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddiscovery.2016.69</ArticleId><ArticleId IdType="pmc">PMC5018544</ArticleId><ArticleId IdType="pubmed">27648302</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol (2016) 7:55. doi: 10.3389/fimmu.2016.00055</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00055</ArticleId><ArticleId IdType="pmc">PMC4764694</ArticleId><ArticleId IdType="pubmed">26941740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavalchin J, Seder RA, Datta SK. The NZB X SWR model of lupus nephritis. i. cross-reactive idiotypes of monoclonal anti-DNA antibodies in relation to antigenic specificity, charge, and allotype. identification of interconnected idiotype families inherited from the normal SWR and the autoimmune NZB parents. J Immunol (1987) 138(1):128&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">2431053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, Agyemang AF, Alimzhanov MB, Degn S, Tsiftsoglou SA, Alicot E, et al. . Complement C4 maintains peripheral b-cell tolerance in a myeloid cell dependent manner. Eur J Immunol (2013) 43(9):2441&#x2013;50. doi: 10.1002/eji.201343412</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201343412</ArticleId><ArticleId IdType="pmc">PMC4086186</ArticleId><ArticleId IdType="pubmed">23749435</ArticleId></ArticleIdList></Reference><Reference><Citation>Berland R, Fernandez L, Kari E, Han JH, Lomakin I, Akira S, et al. . Toll-like receptor 7-dependent loss of b cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 25(3):429&#x2013;40. doi: 10.1016/j.immuni.2006.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.07.014</ArticleId><ArticleId IdType="pubmed">16973388</ArticleId></ArticleIdList></Reference><Reference><Citation>Degn SE, van der Poel CE, Firl DJ, Ayoglu B, Al Qureshah FA, Bajic G, et al. . Clonal evolution of autoreactive germinal centers. Cell (2017) 170(5):913&#x2013;26 e19. doi: 10.1016/j.cell.2017.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.026</ArticleId><ArticleId IdType="pmc">PMC5784431</ArticleId><ArticleId IdType="pubmed">28841417</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DA, Pisalyaput K, Tenner AJ. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem (2010) 112(3):733&#x2013;43. doi: 10.1111/j.1471-4159.2009.06494.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06494.x</ArticleId><ArticleId IdType="pmc">PMC2809134</ArticleId><ArticleId IdType="pubmed">19919576</ArticleId></ArticleIdList></Reference><Reference><Citation>Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity (2007) 40(8):560&#x2013;6. doi: 10.1080/08916930701510673</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930701510673</ArticleId><ArticleId IdType="pubmed">18075790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>